"The collaboration with CyanoCapture is an exciting step forward for Cultivarium's mission to unlock non-model microbes for broad, impactful applications," said Henry Lee, PhD, CEO of Cultivarium. "Cyanobacteria, are exactly the type of organisms that can drive synthetic biology into a new era of ecosystem-based solutions powered by photosynthesis. Together, we're building a pathway for researchers to better understand and engineer photosynthetic microbes to tackle some of the world's biggest challenges."

"Less than 0.01% of microbes out there have been studied. Some of the answers to humanity's biggest challenges, including carbon capture and biomanufacturing, could come from learning to harness photosynthesis. This is what our respective labs do well." added David Kim, CEO of CyanoCapture. "By collaborating with Cultivarium, we are accelerating our ability to tap into new genetic resources that we would otherwise not be able to explore. Together, we aim to make photosynthetic biomanufacturing the method of cost-effectively making bioderived compounds in the future. These are self-dividing, self-repairing, robust cells that could disrupt the way we do manufacturing."